What topics does this cannabis study cover?

This study covers research on: Appetite, Endocannabinoid.

Where was this research published?

Published in Imaging neuroscience (Cambridge, Mass.) on August 26, 2026.

Appetite Endocannabinoid

How the brain’s CB1 system shapes food reward and self-control

Q: What did this research study find?

Higher *CB1 receptor availability* was associated with **stronger anticipatory brain responses to food cues**.

Brain cannabinoid CB1 receptor signaling modulates reward responses and inhibitory control in humans.

Imaging neuroscience (Cambridge, Mass.) • August 26, 2026 • Highly Relevant

🤖

AI Summary

This human study examined how the brain’s endocannabinoid system, particularly the CB1 receptor, may influence appetite-related behavior. Forty-one healthy male participants underwent PET imaging to measure CB1 receptor availability, while fMRI tracked brain responses to food cues and a go/no-go task assessed inhibitory control.

People with higher CB1 receptor availability showed stronger brain responses while anticipating food, alongside reduced activation during inhibitory-control testing. The findings suggest that CB1 signaling may separately influence food reward and the ability to restrain responses. Although the study does not test cannabis, THC, or a treatment, it supports the CB1 receptor as a possible target for future appetite and eating-disorder therapies. The abstract does not provide effect sizes or percentages.

💡 Key Findings

Higher CB1 receptor availability was associated with stronger anticipatory brain responses to food cues.

Good

70%

Higher CB1 receptor availability was also associated with reduced activation during inhibitory-control testing.

Good

70%

The results suggest that CB1 signaling has distinct roles in food reward and inhibitory control, making the receptor a potential therapeutic target for regulating appetite.

Good

70%

The study does not directly test cannabis, THC, or CBD, so its findings cannot establish that cannabis use changes appetite control in people.

High

90%

📄 Original Abstract

The central endocannabinoid system, particularly the in vivo cannabinoid type 1 (CB1) receptor signaling, presents a promising target for treating eating disorders. However, its precise role in appetite control remains unclear. This study aimed to determine how CB1 receptor signaling contributes to key aspects of appetite regulation, specifically anticipatory food reward responses and inhibitory control. Forty-one healthy male participants underwent [18F]FMPEP-d2 positron emission tomography (PET) to quantify CB1 receptor availability. Functional magnetic resonance imaging (fMRI) was used to assess anticipatory neural responses to food cues, while inhibitory control was measured using a go/nogo task. Data show that individuals with higher CB1 receptor availability exhibited stronger anticipatory reward-related neural responses and reduced activation during inhibitory control. Therefore, CB1 receptor signaling plays a distinct role in modulating reward and inhibitory processes related to feeding behavior. The findings suggest that the CB1 receptor may serve as a therapeutic target for regulating appetite.

Paper Type

📄 Research

Publication

Journal: Imaging neuroscience (Cambridge, Mass.)
Published: August 26, 2026
PMID: 42662580
DOI: 10.1162/IMAG.a.1344

Authors (5)

Lihua Sun Huashan Institute of Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Tatu Kantonen Turku PET Centre, University of Turku, Turku, Finland.
Laura Pekkarinen Turku PET Centre, University of Turku, Turku, Finland.
Pirjo Nuutila Turku PET Centre, University of Turku, Turku, Finland.
Lauri Nummenmaa Turku PET Centre, University of Turku, Turku, Finland.

MeSH Keywords

Humans Male Reward Receptor, Cannabinoid, CB1 Brain Magnetic Resonance Imaging Young Adult Adult Positron-Emission Tomography Signal Transduction +2 more